CYCLERION THERAPEUTICS, INC. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/947250a6-03d4-441d-9eb5-590849aa5663/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-5.0M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-132193 |
| FY 2024 | $-3.6M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-032037 |
| FY 2023 | $-13.0M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-025935 |
| FY 2022 | $-18.5M | 2022-01-01 – 2022-12-31 | evidence 0000950170-24-025935 |
| FY 2021 | $-55.2M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-001958 |
| FY 2020 | $-81.3M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-008434 |
| FY 2019 | $-125.0M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-032554 |
| FY 2018 | $-115.3M | 2018-01-01 – 2018-12-31 | evidence 0001104659-20-032554 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CYCLERION THERAPEUTICS, INC. — all facts · Revenue · Net Income